Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Patrick McCormack’s and Tiger Consumer’s Favorite Stock Picks

Patrick McCormack is a hedge fund manager who previously worked at Julian Robertson’s Tiger Management hedge fund. His fund Tiger Consumer Management is one of several funds that were seeded by Julian Robertson. Tiger Consumer was founded in 2006 and as the name implies invests primarily in consumer-related themes. At June 30, the fund’s 13F assets totaled approximately $1.26B.


During the second quarter, McCormack reduced stakes in two significant holdings, Green Mountain Coffee Roasters (GMCR), and kindle maker Amazon (AMZN). The fund cut its holdings in GMCR by 37% and AMZN by 25% during the quarter. Despite the large cuts, these two stocks still account for sizable portion of the fund’s portfolio. GMCR was the fund’s third largest position, with investments of approximately $57.6M. GMCR accounted for 4.6% of the 13F portfolio at the end of June. Amazon was the funds’ 12th largest holding during the same period. The fund owned $51.5M worth of Amazon stock at the end of the quarter and this position accounted for 4.1% of the portfolio.

Both these stocks have outperformed the S&P since July. GMCR lost 4.3% since June and AMZN lost 13.2. This compares very favorably with the 14.6% loss suffered by the S&P 500 index during the same period.

Read the rest of the article here.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!